Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures

被引:0
|
作者
Takayuki Katsube
Ryosuke Shimizu
Takahiro Fukuhara
Takeshi Kano
Toshihiro Wajima
机构
[1] Clinical Pharmacology and Pharmacokinetics,Clinical Research Department
[2] Shionogi & Co.,Project Management Department
[3] Ltd,undefined
[4] Shionogi & Co.,undefined
[5] Ltd,undefined
[6] Shionogi & Co.,undefined
[7] Ltd,undefined
来源
Clinical Pharmacokinetics | 2019年 / 58卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1469 / 1482
页数:13
相关论文
共 50 条
  • [41] DETERMINING THE EPIDEMIOLOGY, PATIENT FLOW, TREATMENT AND UNMET NEEDS OF PATIENTS WITH CHRONIC LIVER DISEASE-ASSOCIATED SEVERE THROMBOCYTOPENIA UNDERGOING INVASIVE PROCEDURES IN SPAIN
    Andrade, R.
    Banares, R.
    Calleja, J. L.
    Crespo, J.
    Esteban, R.
    Jarque, I
    Mingot-Castellano, M.
    Romero-Gomez, M.
    Munoz, R.
    Gil, A.
    Shepherd, J.
    [J]. VALUE IN HEALTH, 2019, 22 : S722 - S722
  • [42] Treatment Options for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing a Scheduled Procedure
    Saab, Sammy
    Bernstein, David
    Hassanein, Tarek
    Kugelmas, Marcelo
    Kwo, Paul
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2020, 54 (06) : 503 - 511
  • [43] The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis
    Lindquist, Ingrid
    Olson, Sven R.
    Li, Ang
    Al-Samkari, Hanny
    Jou, Janice H.
    McCarty, Owen J. T.
    Shatzel, Joseph J.
    [J]. PLATELETS, 2022, 33 (01) : 66 - 72
  • [44] Lusutrombopag Reliably Increases Platelet Counts for up to 3 Weeks in Chronic Liver Disease Patients with Thrombocytopenia Undergoing Invasive Procedures Regardless of Baseline Platelet Counts: Results from Two Phase 3 Trials
    Brown, Robert S., Jr.
    Imawari, Michio
    Izumi, Namiki
    Osake, Yukio
    Bentley, Roy
    Baykal, Tolga
    Ochiai, Toshimitsu
    Kano, Takeshi
    [J]. HEPATOLOGY, 2018, 68 : 1178A - 1179A
  • [45] Thrombopoietin receptor agonist is more effective than platelet transfusion for chronic liver disease with thrombocytopenia, shown by propensity score matching
    Furuichi, Yoshihiro
    Takeuchi, Hirohito
    Yoshimasu, Yuu
    Kasai, Yoshitaka
    Abe, Masakazu
    Itoi, Takao
    [J]. HEPATOLOGY RESEARCH, 2020, 50 (09) : 1062 - 1070
  • [46] Review article: a treatment algorithm for patients with chronic liver disease and severe thrombocytopenia undergoing elective medical procedures in the United States
    Dieterich, Douglas T.
    Bernstein, David
    Flamm, Steven
    Pockros, Paul J.
    Reau, Nancy
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (08) : 1311 - 1322
  • [47] EFFICACY OF AVATROMBOPAG IN OPTIMIZING PLATELET COUTNS IN PATIENTS WITH CHRONIC LIVER DISEASE AND THROMBOCYTOPENIA UNDERGOING GI PROCEDURES
    Brelvi, Zamir
    Allen, Lee F.
    Aggarwal, Kavita
    Vredenburg, Michael
    Tian, Wei
    Franklin, Howard
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S1336 - S1336
  • [48] EFFECT OF THROMBOPOIETIN RECEPTOR AGONIST IS HIGHER THAN THAT OF PLATELET TRANSFUSION IN CHRONIC LIVER DISEASE WITH THROMBOCYTOPENIA -FROM PROPENSITY SCORE MATCHING-
    Furuichi, Yoshihiro
    Takeuchi, Hirohito
    Abe, Masakazu
    Kasai, Yoshitaka
    Itoi, Takao
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S113 - S113
  • [49] Lusutrombopag for Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Who Are Undergoing Non-Emergency Invasive Procedures: Results from An International Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (L-PLUS 2)
    Afdhal, Nezam H.
    Duggal, Ajay
    Ochiai, Toshimitsu
    Motomiya, Tomoko
    Kano, Takeshi
    Nagata, Tsutae
    Peck-Radosavljevic, Markus
    [J]. HEPATOLOGY, 2017, 66 (06) : 1254A - 1254A
  • [50] Stable Liver Function during Long-Term Administration of Eltrombopag, a Thrombopoietin Receptor Agonist, in Patients with Chronic Liver Disease
    Kurokawa, Tomohiro
    Murata, Soichiro
    Ohkohchi, Nobuhiro
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 240 (04): : 277 - 279